Company news

Avecho Biotechnology Limited (ASX:AVE) news

Avecho Biotechnology Limited news releases on 6ix. Latest, Oct 17, 2019: Terumo return rights to TPM/Propofol Injectable

View Avecho Biotechnology Limited →

Press releases — page 3

Terumo return rights to TPM/Propofol Injectable

October 16, 2019

Ashland purchases manufacturing rights for Vital ET and TPM

June 19, 2019

FDA meeting provides guidance for TPM/Oxymorphone patch

January 17, 2019

Reinstatement to Offical Quotation

December 18, 2018

Suspension from Official Quotation

December 11, 2018

Phosphagenics Arbitration Award Issued

November 11, 2018

Phosphagenics Receives Further Arbitration Process Update

October 22, 2018

Phosphagenics Licensing Agreement Update

September 9, 2018

Half Year Accounts

August 13, 2018

AGM Chairmans Address and CEO Presentation

May 24, 2018

Terumo Shifts Focus From Oxymorphone Patch to Injectables

March 19, 2018

Preliminary Final Report

February 27, 2018

Phosphagenics Placement Secures A$1.37 million

January 17, 2018

Phosphagenics Receipt of R&D Tax Incentive

January 16, 2018

Phosphagenics Announces Results of Dairy Trial

December 21, 2017

TPM Improves Negative Effects of Heat Stress in Poultry

December 14, 2017

Phosphagenics Multinational License for TPM in Personal Care

December 3, 2017

Phosphagenics Update on TPM/Propofol Development Program

November 8, 2017

Phosphagenics Entitlement Offer Information Booklet

October 3, 2017

Phosphagenics Announces Equity Raising

September 26, 2017

Phosphagenics Signs Term Sheet TPM Diclofenac Gel in Asia

September 25, 2017

Phosphagenics Market Update - Potential Return of Capital

September 1, 2017

June 2017 Half-year Financial Report and Appendix 4D

August 31, 2017

Phosphagenics Signs Patch Development Agreement with Terumo

August 22, 2017

Phosphagenics Sells BioElixia Brand to Pure Beauty Australia

August 9, 2017

POH Mylan Arbitration Update- Expert Report on Damages Filed

May 28, 2017

Phosphagenics and IAH Cease All Partnerships

March 9, 2017

Appendix 4E and Annual Financial Report

February 28, 2017

Phosphagenics Non-Binding Term Sheet for OxyM Patch in Japan

January 30, 2017

Phosphagenics Poultry Feed Study Reports Positive Data

December 14, 2016

Reformulation TPM/Oxymorphone Complete

December 11, 2016

Phosphagenics ProPhase Arbitration Ruling Handed Down

November 16, 2016

S&P DJ Indices Announces March Quarterly Rebalance

November 7, 2016

Phosphagenics Updates Long Term Incentive Scheme

September 11, 2016

Phosphagenics Begins Feed Efficiency Study in Poultry

August 31, 2016

June 2016 Half-year Financial Report and Appendix 4D

August 25, 2016

Phosphagenics Completes Grower/Finisher Pig Study

June 29, 2016

Phosphagenics Initiates Cattle Study

June 1, 2016

Phosphagenics Expands Licence Agreement for Diclofenac Gel

May 18, 2016

Phosphagenics Expands Japanese Option to Oxycodone Patch

May 17, 2016

Phosphagenics Signs Japanese License Option and R&D Alliance

April 29, 2016

Successful Results -Phase 2 TPM Trentinoin Gel Study on Acne

March 30, 2016

Receipt of $2.4m R&D Tax Incentive

March 29, 2016

Phosphagenics Announces Results of TPM/Oxycodone Ph2a Trial

February 11, 2016

Positive Results for Weaner Pig Feed Efficiency Trial

February 10, 2016

← Newer